Challenges with benchmarking of MDMA-assisted psychotherapy
Peer reviewed, Journal article
Published version
Date
2021Metadata
Show full item recordCollections
- Institutt for psykologi [2885]
- Publikasjoner fra CRIStin - NTNU [37219]
- Publikasjoner fra Cristin - St. Olavs hospital [1459]
- St. Olavs hospital [2441]
Abstract
To represent a treatment breakthrough, 3,4-methylenedioxymethamphetamine (MDMA)-assisted psychotherapy for post-traumatic stress disorder (PTSD) should be evaluated against first-line psychological interventions or for prespecified patient subgroups that do not improve after such interventions.